| 5-R01-EB031935-04 |
A high-performance and versatile technology for precision microbiome engineering |
Harris Wang |
Columbia University Health Sciences |
| 5-R21-EB033595-02 |
A Molecular Grammar for Guide RNAs (gRNAs) with Engineered Secondary Structures |
Yirong Mo |
University of North Carolina Greensboro |
| 1-R01-EB037456-01 |
A molecular toolbox for thermal control of programmed cell death in animals |
Lukasz Bugaj |
University of Pennsylvania |
| 1-DP2-EB035891-01 |
A Novel Class of Synthetic Receptors to Empower the Age of mRNA Therapies |
Xiaojing Gao |
Stanford University |
| 1-R21-EB033459-01A1 |
A Novel Vector Platform to Actualize T Cell Modification In Vivo |
David Curiel |
Washington University |
| 1-K99-EB036553-01 |
AN ADAPTIVE FRAMEWORK TO SYNTHESIZE AND RECONFIGURE BACTERIAL VIRUSES (PHAGES) TO COUNTER ANTIBIOTIC RESISTANCE |
Yan Zhang |
California Institute of Technology |
| 1-R03-EB036096-01 |
Bioengineering of Customized Exosomes as a Cell-free Therapy for Volumetric Muscle Loss Injuries Proposal |
Prabaha Sikder |
Cleveland State University |
| 5-R21-EB035208-02 |
Computationally designed, small molecule-responsive cell receptors for treating solid tumors |
Anum Glasgow |
Columbia University Health Sciences |
| 5-R21-EB036298-02 |
Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution |
Shannon Miller |
Scripps Research Institute, The |
| 5-R01-EB031124-04 |
Directed evolution of a sequence-specific targeting technology for therapeutic gene delivery to the human genome. |
Jesse Owens |
University of Hawaii at Manoa |
